AU2006340699A1 - Live attenuated salmonella vaccine - Google Patents

Live attenuated salmonella vaccine Download PDF

Info

Publication number
AU2006340699A1
AU2006340699A1 AU2006340699A AU2006340699A AU2006340699A1 AU 2006340699 A1 AU2006340699 A1 AU 2006340699A1 AU 2006340699 A AU2006340699 A AU 2006340699A AU 2006340699 A AU2006340699 A AU 2006340699A AU 2006340699 A1 AU2006340699 A1 AU 2006340699A1
Authority
AU
Australia
Prior art keywords
strain
mutant strain
mutant
vaccine
attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006340699A
Other languages
English (en)
Inventor
Connie Theresia Adriaensen
Henri Marcel Jozef De Greve
Jean-Pierre Ernest Clement Hernalsteens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vrije Universiteit Brussel VUB
Original Assignee
Vrije Universiteit Brussel VUB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vrije Universiteit Brussel VUB filed Critical Vrije Universiteit Brussel VUB
Publication of AU2006340699A1 publication Critical patent/AU2006340699A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2006340699A 2006-03-20 2006-03-20 Live attenuated salmonella vaccine Abandoned AU2006340699A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BE2006/000019 WO2007106956A1 (en) 2006-03-20 2006-03-20 Live attenuated salmonella vaccine

Publications (1)

Publication Number Publication Date
AU2006340699A1 true AU2006340699A1 (en) 2007-09-27

Family

ID=37430822

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006340699A Abandoned AU2006340699A1 (en) 2006-03-20 2006-03-20 Live attenuated salmonella vaccine

Country Status (7)

Country Link
EP (1) EP2004802A1 (ja)
JP (1) JP2009529895A (ja)
AU (1) AU2006340699A1 (ja)
BR (1) BRPI0621489A2 (ja)
CA (1) CA2646421A1 (ja)
MX (1) MX2008012056A (ja)
WO (1) WO2007106956A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080260777A1 (en) 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
US9050283B2 (en) 2009-01-16 2015-06-09 University Of Maryland, Baltimore Broad spectrum vaccine against non-typhoidal Salmonella
US9011871B2 (en) 2011-11-07 2015-04-21 University Of Maryland, Baltimore Broad spectrum vaccine against typhoidal and non-typhoidal Salmonella disease
CZ307672B6 (cs) * 2012-05-30 2019-02-13 VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. Vakcína pro orální podání hospodářským zvířatům
CN119842745A (zh) * 2025-01-03 2025-04-18 扬州大学 鼠伤寒沙门菌毒力基因Ict的鉴定及其减毒疫苗候选株的制备与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190669B1 (en) * 1998-05-13 2001-02-20 University Of Maryland, Baltimore Attenuated mutants of salmonella which constitutively express the Vi antigen

Also Published As

Publication number Publication date
WO2007106956A1 (en) 2007-09-27
JP2009529895A (ja) 2009-08-27
BRPI0621489A2 (pt) 2011-12-13
MX2008012056A (es) 2008-12-18
CA2646421A1 (en) 2007-10-11
EP2004802A1 (en) 2008-12-24

Similar Documents

Publication Publication Date Title
EA036764B1 (ru) Ослабленный штамм streptococcus suis, индуцирующий иммунный ответ у свиней, и его применение
US20110052635A1 (en) Live attenuated salmonella vaccine
EA027981B1 (ru) Вакцина против пневмонии, вызываемой streptococcus pneumoniae, на основе гибридного белка
Shahidi et al. The design and application of a bacterial ghost vaccine to evaluate immune response and defense against avian pathogenic Escherichia coli O2: K1 serotype
EP2032687B1 (en) Salmonella enterica strains of reduced pathogenicity, method for their preparation and uses thereof
ES2824402T3 (es) Vacunas atenuadas contra Pasteurella multocida y procedimientos de fabricación y uso de las mismas
CN102140430A (zh) 一种不含抗性标记的鼠伤寒沙门氏菌基因缺失突变菌株、疫苗及应用
Schrøder et al. Early vaccination and protection of Atlantic cod (Gadus morhua L.) juveniles against classical vibriosis
CN101914564B (zh) 一种大肠杆菌多个肠毒素基因的融合体及其应用
AU2006340699A1 (en) Live attenuated salmonella vaccine
Gerasimova et al. Avian colibacillosis—Current aspects
CN102676419B (zh) 一种伤寒沙门氏菌基因缺失菌株及由其制备的疫苗和应用
US20170008935A1 (en) Mutated salmonella enteriaca
Zhao et al. Identification of a gene in Riemerella anatipestifer CH-1 (B739-2187) that contributes to resistance to polymyxin B and evaluation of its mutant as a live attenuated vaccine
US9161972B2 (en) Modified live flavobacterium strains, stabilized vaccines comprising same, and methods of making and use thereof
US20100260794A1 (en) Live attenuated salmonella vaccine
CN106661544B (zh) 用于牲畜生产系统的疫苗
KR20080110594A (ko) 약독화 살모넬라 생백신
KR102007455B1 (ko) 방사선에 의한 약독화 생균 백신의 제조 방법 및 이로부터 제조된 약독화 생균 백신 조성물
KR20080105099A (ko) 약독화 살모넬라 생백신
KR101950931B1 (ko) ptsI 및 crr 유전자 결손된 약독화 살모넬라 타이피뮤리움 균주 및 상기 균주를 이용한 생균 백신 조성물
US11541109B2 (en) Method for preparing live attenuated vaccine by irradiation and live attenuated vaccine composition prepared by the same
Sen et al. Immunogenicity and duration of immunity of the polyvalent vaccine against chicken salmonellosis
KR101774863B1 (ko) 살모넬라증 치료를 위한 변이 균주 ｈｉｄ２０９２와 ｈｉｄ２１１４ 및 이를 포함하는 살모넬라증 약제학적 조성물
Pumtang-on Investigation of Campylobacter jejuni and Campylobacter coli colonisation of commercial free-range chickens

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application